ES508985A0 - Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces. - Google Patents

Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces.

Info

Publication number
ES508985A0
ES508985A0 ES508985A ES508985A ES508985A0 ES 508985 A0 ES508985 A0 ES 508985A0 ES 508985 A ES508985 A ES 508985A ES 508985 A ES508985 A ES 508985A ES 508985 A0 ES508985 A0 ES 508985A0
Authority
ES
Spain
Prior art keywords
antibiotic compound
obtaining
new antibiotic
streptomyces strain
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES508985A
Other languages
English (en)
Other versions
ES8301274A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8301274A1 publication Critical patent/ES8301274A1/es
Publication of ES508985A0 publication Critical patent/ES508985A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/003Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces
    • Y10S435/897Streptomyces griseus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES508985A 1981-01-23 1982-01-22 Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces. Granted ES508985A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813102137 DE3102137A1 (de) 1981-01-23 1981-01-23 Neue antibiotisch wirksame verbindung, komponente b, mikrobiologisches verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ES8301274A1 ES8301274A1 (es) 1982-11-16
ES508985A0 true ES508985A0 (es) 1982-11-16

Family

ID=6123195

Family Applications (1)

Application Number Title Priority Date Filing Date
ES508985A Granted ES508985A0 (es) 1981-01-23 1982-01-22 Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces.

Country Status (6)

Country Link
US (2) US4415557A (es)
EP (1) EP0057349B1 (es)
JP (1) JPS57143000A (es)
AT (1) ATE8132T1 (es)
DE (2) DE3102137A1 (es)
ES (1) ES508985A0 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3126389A1 (de) * 1981-07-03 1983-02-10 Bayer Ag, 5090 Leverkusen Neue antibiotisch wirksame verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3236389A1 (de) * 1982-10-01 1984-04-05 Bayer Ag, 5090 Leverkusen Neue nucleosidverbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3341571A1 (de) * 1983-11-17 1985-05-30 Bayer Ag, 5090 Leverkusen Neue antibiotika, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und zwischenprodukte zu ihrer herstellung
US6410056B1 (en) * 1984-03-16 2002-06-25 The United States Of America As Represented By The Secretary Of The Army Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
US6306647B1 (en) 1987-06-16 2001-10-23 Ajinomoto Co., Inc. Process for producing and purifying 2′,3′-dideoxynucleosides, and process for producing 2′,3′-dideoxy-2′,3′-didehydronucleosides
US4835104A (en) * 1987-06-16 1989-05-30 Ajinomoto Co., Inc., Patent & Licensing Department Process for producing and purifying 2',3'-dideoxynucleosides, and process for producing 2',3'-dideoxy-2',3'-didehydronucleosides
US5869679A (en) * 1997-11-10 1999-02-09 Transcend Therapeutics, Inc. Methods for preparing l-2-oxothiazolidine-4-carboxylate and its carboxylic acid
CN113149990B (zh) * 2020-01-23 2024-04-02 嘉圣生物医药(嘉兴)有限公司 铁载体-二氢叶酸还原酶抑制剂偶联物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB639943A (en) * 1947-02-17 1950-07-12 Upjohn Co Improved method of producing bio-synthetic antimicrobial substances
US4158608A (en) * 1975-08-20 1979-06-19 Bayer Aktiengesellschaft Fungicidally active antibiotic from Streptomyces tendae Ettlinger
DE3020722A1 (de) * 1980-05-31 1981-12-10 Bayer Ag, 5090 Leverkusen Verfahren zur anreicherung von nikkomycin-gemischen

Also Published As

Publication number Publication date
ES8301274A1 (es) 1982-11-16
EP0057349B1 (de) 1984-06-27
DE3102137A1 (de) 1982-08-19
EP0057349A3 (en) 1982-09-01
US4415557A (en) 1983-11-15
ATE8132T1 (de) 1984-07-15
DE3260277D1 (en) 1984-08-02
EP0057349A2 (de) 1982-08-11
JPS57143000A (en) 1982-09-03
US4546079A (en) 1985-10-08

Similar Documents

Publication Publication Date Title
DK518683A (da) Fremgangsmaade til fremstilling af 4aeepi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og mellemprodukter ved fremgangsmaaden
HUP9900492A2 (hu) 3,6-Ketál és enol-éter makrolid antibiotikumok és ezeket tartalmazó gyógyszerkészítmények
AU2005099A (en) Methods and compositions for the treatment and prevention of (staphylococcus aureus) infections
ES508985A0 (es) Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces.
DK165120C (da) Basiske monokarboxyamidderivater af actagardin, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende derivaterne
MX9708611A (es) Compuestos de dialquiltiacumicina.
IL57853A (en) Sisomycin derivatives,their production and pharmaceutical compositions and fodder containing them
ES508984A0 (es) Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces.
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
MY110998A (en) Antibiotic combination
ES8402286A1 (es) Procedimiento para la obtencion de antibiotico de p-lactama.
ES8707955A1 (es) Un procedimiento para la preparacion pirazolidinonas biciclicas'
IL66192A0 (en) Antibiotic compounds,their production and pharmaceutical compositions containing them
MX9205996A (es) Nuevo compuesto antibiotico con actividad antitumoral, composicion farmaceutica que lo contiene y procedimiento para su preparacion.
DK482383A (da) Fremgangsmaade til fremstilling af et antibiotisk stof betegnet nargenicin c1
ES2038244T3 (es) Procedimiento para preparar un nuevo antibiotico, fumifungina, y su empleo como medicamento.
AU7743287A (en) A new macrolide antibiotic, a microbiological process for its preparation, and its use as a medicinal agent
IT1190651B (it) Antibiotici macrolidici semisintetici,procedimento microbiologico per la loro preparazione e relatico microorganismo,intermedio per la loro preparazione e composizioni farmaceutiche che li contengono
JPS548792A (en) Novel preparation of ribostamycin
MX9708385A (es) Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.
JPS53144502A (en) New antibiotics tridecaptin b and its preparation

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001009